On June 16–18, Meshalkin National Medical Research Centre in Novosibirsk hosted the XI educational and scientific conference dedicated to the memory of Academician E.N. Meshalkin Patients with Comorbidities – Modern Treatment Insights and New Horizons in the 21st Century.
This major event brought together participants from more than 30 cities and 13 countries and featured 20 breakout sessions with more than 17 lectures by prominent Russian and foreign scientists. World experts shared their experience and presented the results of cutting-edge research in the field of surgery.
The increase in life expectancy of the people in need of surgical care is clearly associated with comorbidity. This entails the need to increase the number of life-saving minimally invasive procedures with minimal surgical aggression.
In his presentation, Head of the Research Department of Vascular and Interventional Surgery Dr. Mikhail Chernyavsky summarized the results of the department and spoke about current trends in the hybrid surgical treatment of aortic and peripheral arterial lesions. Dr. Chernyavsky highlighted that due to the advent of innovations at Almazov Centre surgical care is possible even to those patients who were previously denied treatment. In just a few years, the number of high-tech minimally invasive procedures has increased many times in the clinic of vascular surgery. The surgeons of the Centre have mastered such unique techniques as the MitraClip endovascular mitral valve repair, transcatheter aortic valve implantation, aortic arch replacement with in situ stent graft fenestration, and many others.
Scientific events bring together experts from different parts of the world and promote the development of science and the generation of innovative treatment approaches. Such conferences make it possible to share knowledge and experience and serve as a good starting point for future scientific progress in cardiovascular surgery in Russia.